Science Explorer Interactive view Map
Topic · Public Health, Environmental and Occupational Health

Gestational Trophoblastic Disease Studies

Gestational Trophoblastic Disease Studies is a research topic within Public Health, Environmental and Occupational Health. Science Explorer counts 11k research works in it since 1950. 13.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, management, and genetic aspects of gestational trophoblastic disease, including hydatidiform mole, choriocarcinoma, and placental site trophoblastic tumor. It covers topics such as epidemiology, pathology, clinical presentation, treatment outcomes, and molecular genetics of these conditions.

  • Gestational Trophoblastic Disease
  • Hydatidiform Mole
  • Choriocarcinoma
  • Trophoblastic Tumor
  • Molar Pregnancy
  • Placental Site Trophoblastic Tumor
  • Genetic and Epigenetic Analysis
  • Chemotherapy
  • Immunohistochemistry
  • Prenatal Diagnosis
Research works
11k
fractional, since 1950
In the world top 10%
1.5k
per year above
Top-10% rate
13.3%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+20%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Gestational Trophoblastic Disease Studies research?

By volume, the United States and China publish the most (308 and 238 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 308 works
  2. 2 China 238 works
  3. 3 India 173 works
  4. 4 Japan 88 works
  5. 5 United Kingdom 66 works
  6. 6 Brazil 48 works
  7. 7 Iran 45 works
  8. 8 Türkiye 44 works
  9. 9 Indonesia 41 works
  10. 10 Italy 39 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 28.3%China: 21.8%India: 15.9%Japan: 8.1%6 others listed: 26.0%28%largest
United States308 · 28.3%China238 · 21.8%India173 · 15.9%Japan88 · 8.1%6 others listed283 · 26.0%

Shares of the rows listed above, not of the whole node.

Which institutions lead Gestational Trophoblastic Disease Studies research?

By volume in 2022–2025, Yale University publishes the most Gestational Trophoblastic Disease Studies research, followed by All India Institute of Medical Sciences and Women's Hospital, School of Medicine, Zhejiang University.

By volume, 2022–2025

  1. 1 Yale UniversityUnited States 10 works
  2. 2 All India Institute of Medical SciencesIndia 9 works
  3. 3 Women's Hospital, School of Medicine, Zhejiang UniversityChina 9 works
  4. 4 University of California, San FranciscoUnited States 8 works
  5. 5 Centre Hospitalier Universitaire Hassan IIMorocco 8 works
  6. 6 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 7 works
  7. 7 Tehran University of Medical SciencesIran 7 works
  8. 8 Sichuan UniversityChina 7 works
  9. 9 Peking Union Medical College HospitalChina 7 works
  10. 10 Airlangga UniversityIndonesia 7 works

Who are the leading researchers in Gestational Trophoblastic Disease Studies?

The most-cited researchers publishing on Gestational Trophoblastic Disease Studies include Ross S. Berkowitz.

  1. 1 Ross S. Berkowitz United States 1.7k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Gestational Trophoblastic Disease Studies research done?

The largest centres of Gestational Trophoblastic Disease Studies research in 2022–2025 are Beijing (China), Hangzhou (China), London (United Kingdom) and New Delhi (India).

Largest cities, 2022–2025

  1. 1 Beijing China 28 works
  2. 2 Hangzhou China 28 works
  3. 3 London United Kingdom 23 works
  4. 4 New Delhi India 21 works
  5. 5 Tehran Iran 20 works
  6. 6 Tokyo Japan 16 works
  7. 7 Guangzhou China 16 works
  8. 8 Chengdu China 16 works
  9. 9 Mumbai India 15 works
  10. 10 Shanghai China 15 works
See Gestational Trophoblastic Disease Studies on the map

Where is the best place to study Gestational Trophoblastic Disease Studies?

Among universities, judged by research, All India Institute of Medical Sciences, University of California, San Francisco and Yale University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 All India Institute of Medical SciencesIndia 66.217.2%9.3×9 +66.3%
2 University of California, San FranciscoUnited States 55.220.1%7.8×8 +17.5%
3 Yale UniversityUnited States 40.28.9%6.2×10 -61.3%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Gestational Trophoblastic Disease Studies research growing?

Output in 2018–2022 was 20% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Gestational Trophoblastic Disease Studies.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.